EMA makes 'extensive changes' to list of class waivers for pediatric investigation plans
This article was originally published in SRA
Executive Summary
Big changes are afoot at the European Medicines Agency regarding the regulation of pediatric medicines.
You may also be interested in...
EMA's Revised Pediatric Class Waiver List Comes Into Effect July 28
Marketing authorization applications for medicines that are no longer subject to a class waiver as per the revised list will need a pediatric investigation plan.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.